Dihydropinosylvin

Dihydropinosylvin

SCHEMBL501070

Oc1cc(O)cc(CCc2ccccc2)c1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.70
OPRK1 P41145 3/20 0.53
GPR84 Q9NQS5 1/20 0.53
TYR P14679 1/20 0.52
TDP1 Q9NUW8 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
SLC5A1 P13866 1/20 0.50
SLC5A2 P31639 1/20 0.50
ADRB2 P07550 2/20 0.49
OPRM1 P35372 2/20 0.48
OPRD1 P41143 2/20 0.48
GABRA1 P14867 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA3 P34903 1/20 0.48
GABRA2 P47869 1/20 0.48
GABRB2 P47870 1/20 0.48
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11676009 0.91 LTA4H (0.58) LTA4HOPRK1GPR84IGF1RALOX15
SCHEMBL31544883 0.89 PTGS2 (0.61) LTA4HGPR84MAPTIGF1RALOX15
SCHEMBL31545505 0.89 PTGS2 (0.61) LTA4HGPR84MAPTIGF1RALOX15
Resorcinol SCHEMBL4639098 0.85 OPRK1 (0.64) OPRK1TDP1OPRM1OPRD1MAOA
SCHEMBL17706592 0.85 ADRB2 (0.63) LTA4HOPRK1GAAMAPTADRB2
SCHEMBL13252936 0.85 LTA4H (0.52) LTA4HOPRK1GPR84TDP1GAA
SCHEMBL10149325 0.84 LTA4H (0.74) LTA4HTYRGABRA1GABRG2GABRB3
SCHEMBL23754287 0.83 GABRA1 (0.67) LTA4HOPRK1TYROPRM1OPRD1
3-Phenethylphenol SCHEMBL717571 0.83 OPRK1 (0.74) OPRK1OPRM1OPRD1GABRA1GABRG2
SCHEMBL8947211 0.83 GABRA1 (0.67) LTA4HOPRK1TYROPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078269-A1 POLYMERIC COMPOSITIONS WITH STILBENE-BASED PROCESSING AIDS Cambium Biomaterials, Inc. (US) 2026-03-19 US claimed
WO-2024249297-A2 POLYMERIC COMPOSITIONS WITH PRENYLATED STILBENES Cambium Biomaterials, Inc. (US) 2024-12-05 WO claimed
WO-2024249314-A1 PRENYLTRANSFERASES FOR PRENYLATING STILBENES GINKGO BIOWORKS, INC. (US) 2024-12-05 WO claimed
CN-118459320-A Dihydro pinus koraiensis Process for the preparation of a vegetable 厦门沃克沃德医药科技有限公司 2024-08-09 CN claimed
US-20240026314-A1 POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS ROTHSTEIN STEVEN (CA) 2024-01-25 US claimed
EP-4251758-A1 POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS Rothstein, Steven (CA) 2023-10-04 EP claimed
US-20230225985-A1 TERPENOPHENOLIC COMPOUNDS AND THEIR USE PHYTOTHERAPEUTIX LIMITED (GB) 2023-07-20 US claimed
CN-116194431-A Terpene phenol compound and application thereof 植物疗法有限公司 2023-05-30 CN claimed
EP-4126800-A1 TERPENOPHENOLIC COMPOUNDS AND THEIR USE PHYTOTHERAPEUTIX LTD (GB) 2023-02-08 EP claimed
WO-2022109736-A1 POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS ROTHSTEIN STEVEN (CA) 2022-06-02 WO claimed
EP-2252154-A2 METHOD FOR MINIMIZING THE CYTOTOXICITY OF THE EFFECTIVE AGENT IN A COMPOSITION THAT IS ADMINISTERED TO A MAMMAL OR GETS INTO CONTACT WITH A MAMMAL Oy Granula AB LTD (FI) 2010-11-24 EP claimed
EP-2252155-A2 METHOD FOR MINIMIZING THE CYTOTOXICITY OF THE EFFECTIVE AGENT INHIBITING THE GROWTH OF MICRO-ORGANISMS AND FOR MAXIMIZING THE EFFECT Oy Granula AB LTD (FI) 2010-11-24 EP claimed
US-20100129302-A1 ANTIMICROBIAL COMPOSITION WITH LOW CYTOTOXICITY OY GRANULA AB LTD (FI) 2010-05-27 US claimed
US-20100129304-A1 METHOD FOR PREPARING A COMPOSITION COMPRISING A COMPOUND MIXTURE AND A CARRIER AGENT OY GRANULA AB LTD (FI) 2010-05-27 US claimed
WO-2009101261-A2 METHOD FOR MINIMIZING THE CYTOTOXICITY OF THE EFFECTIVE AGENT IN A COMPOSITION THAT IS ADMINISTERED TO A MAMMAL OR GETS INTO CONTACT WITH A MAMMAL OY GRANULA AB LTD (FI) 2009-08-20 WO claimed
WO-2009101262-A2 METHOD FOR MINIMIZING THE CYTOTOXICITY OF THE EFFECTIVE AGENT INHIBITING THE GROWTH OF MICRO-ORGANISMS AND FOR MAXIMIZING THE EFFECT OY GRANULA AB LTD (FI) 2009-08-20 WO claimed
EP-1395539-B1 A METHOD FOR ISOLATING PHENOLIC SUBSTANCES OR JUVABIONES FROM WOOD COMPRISING KNOTWOOD ARBONOVA AB OY (FI) 2009-04-22 EP claimed
US-20040199032-A1 Method for isolating phenolic substances or javabiones from wood comprising knotwood HOLMBOM BJARNE (FI) 2004-10-07 US claimed
EP-1395539-A1 A METHOD FOR ISOLATING PHENOLIC SUBSTANCES OR JUVABIONES FROM WOOD COMPRISING KNOTWOOD Holmbom, Bjarne (FI) 2004-03-10 EP claimed
WO-2002098830-A1 A METHOD FOR ISOLATING PHENOLIC SUBSTANCES OR JUVABIONES FROM WOOD COMPRISING KNOTWOOD HOLMBOM BJARNE (FI) 2002-12-12 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225985-A1 TERPENOPHENOLIC COMPOUNDS AND THEIR USE TPMT, MALT1, UGT1A1 LTA4H 3059/4885OPRK1 211/4885GPR84 2704/4885
US-20100129302-A1 ANTIMICROBIAL COMPOSITION WITH LOW CYTOTOXICITY CUTA, LCT, PYCARD LTA4H 440/4885OPRK1 3503/4885GPR84 2558/4885
US-20260078269-A1 POLYMERIC COMPOSITIONS WITH STILBENE-BASED PROCESSING AIDS SMCHD1, TERB1, NLRP3 LTA4H 872/4885OPRK1 3098/4885GPR84 3665/4885
US-20100129304-A1 METHOD FOR PREPARING A COMPOSITION COMPRISING A COMPOUND MIXTURE AND A CARRIER AGENT H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, BAK1, PMAIP1 LTA4H 82/4885OPRK1 3372/4885GPR84 2354/4885
US-20240026314-A1 POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS COMT, PNMT, GNMT LTA4H 3569/4885OPRK1 3210/4885GPR84 3778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.